PRMT1-mediated methylation controls OFIP ubiquitination and centrosome duplication to maintain epidermal homeostasis
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2532363123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Kai Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Protein Science, Department of Genetics and Cell Biology, Cancer Biolog…. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Centrosome, Homeostasis, Epidermis. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), MOST | National Key Research and Development Program of China (NKPs).
Abstract (Originalsprache)
Epidermal homeostasis relies on the precise balance between the self-renewal and differentiation of basal keratinocytes, a process highly dependent on the fidelity of cell division and centrosome function. However, the molecular mechanism regulating this process remains poorly understood. Here, we identify protein arginine methyltransferase 1 (PRMT1) as a crucial orchestrator of epidermal homeostasis. Genetic ablation of Prmt1 in mice causes severe epidermal hyperplasia characterized by aberrant expansion of the stratum basale and disruption of the mitotic fidelity of basal cells. Mechanistically, PRMT1 directly interacts with and catalyzes the asymmetric arginine dimethylation of the centrosomal OFD1/FOR20-interacting protein (OFIP) at arginine 50. This methylation is required for the subsequent recognition and ubiquitination of OFIP by the E3 ubiquitin ligase STUB1. Consequently, PRMT1 deficiency prevents OFIP methylation and degradation, resulting in its dramatic accumulation at the centrosome. This buildup drives aberrant centrosome overduplication and the formation of multipolar spindles, ultimately compromising the integrity of epidermal renewal. Our findings delineate the PRMT1–OFIP–STUB1 axis as a mechanistic framework governing centrosome numerosity and epidermal homeostasis, advancing understanding of cutaneous barrier integrity and providing a potential therapeutic target for dermatopathological conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Protein Science, Department of Genetics and Cell Biology, Cancer Biology Center, College of Life Sciences, Nankai University, Tianjin 300071,…
- Center for Cell Structure and Function, College of Life Sciences, Shandong Normal University, Jinan 250014, China.
- School of Basic Medicine, Gannan Medical University, Ganzhou 341000, China.
ORCID-Profile: Kai Liu, Die Hu, Dengwen Li, Huijie Zhao, Jun Zhou
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- MOST | National Key Research and Development Program of China (NKPs)
Zitieren
APA
Liu, K., Song, T., Zhao, J., Yan, S., Bu, W., Zhang, S., Hu, D., Li, D., Zhao, H., & Zhou, J. (2026). PRMT1-mediated methylation controls OFIP ubiquitination and centrosome duplication to maintain epidermal homeostasis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2532363123
Vancouver
Liu K, Song T, Zhao J, Yan S, Bu W, Zhang S, et al. PRMT1-mediated methylation controls OFIP ubiquitination and centrosome duplication to maintain epidermal homeostasis. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2532363123
BibTeX
@article{Liu2026,
author = {Liu, Kai and Song, Ting and Zhao, Junkui and Yan, Shaodong and Bu, Weiwen and Zhang, Shenying and Hu, Die and Li, Dengwen and Zhao, Huijie and Zhou, Jun},
title = {PRMT1-mediated methylation controls OFIP ubiquitination and centrosome duplication to maintain epidermal homeostasis},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2532363123}
}
EUVIMED